[{"Assets_0_FY_USD":618009000.0,"CommonStockSharesOutstanding_0_FY_shares":51735732.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":69131000.0,"NetIncomeLoss_1_FY_USD":17545000.0,"NetIncomeLoss_4_FY_USD":63145000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":52149000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":51358000.0,"StockholdersEquity_0_FY_USD":560175000.0,"EarningsPerShareBasic_4_FY_USD":1.23,"EarningsPerShareBasic_1_FY_USD":0.34,"EarningsPerShareDiluted_1_FY_USD":0.33,"EarningsPerShareDiluted_4_FY_USD":1.21,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":402252000.0,"Ticker":"NEOG","CIK":"711377","name":"NEOGEN CORP","OfficialName":"Neogen Corporation Common Stock","form":"10-K","period":"20180531","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3158444013.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20180727"}]